Drug Database
Back to search

Belgium· BE-AMP-SAM238393-00

Balsoclase Antitussivum 2.13 mg/ml

A pentoxyverine product containing pentoxyverine citrate, registered in Belgium by Pierre Fabre Médicament. The same ATC class is registered in 6 of our 19 countries.

ATC R05DB05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedBalsoclase Antitussivum 2.13 mg/mlATCR05DB05REGISTER NO.BE-AMP-SAM238393-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pentoxyverine citrateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pentoxyverine is registered in 6 of 19 countries.

Countries holding a registration under ATC R05DB05 (pentoxyverine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose
Search pentoxyverine products by name

Pentoxyverine · ATC R05DB05

6 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Pentoxyverine Citrate
Manufacturer
Pierre Fabre Médicament
Country
Belgium (BE)
ATC code
R05DB05
ATC class
Pentoxyverine
Defined daily dose
0.1 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    1635010

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

260 interactions on record for pentoxyverine.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pentoxyverine against other medicinesHow interaction checks work

Pentoxyverine · interactions on record

260 records

  • 7 severe
  • 253 moderate

Most severe, free to view

  • ProcarbazineL01XB01severe
  • SelegilineN04BD01severe
  • RasagilineN04BD02severe
  • SafinamideN04BD03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pentoxyverine in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pentoxyverine products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Austria · Mucomat Hustenstiller
  • Germany · Pentoxyverin Al, Sedotussin Hustenstiller
  • Spain · Bisolvon Calmatos
  • Finland · Biseltoc
  • France · Clarix Adultes Édulcorée Au Maltitol Liquide, Clarix Enfants
  • Italy · Pentοssiverina Opella Healthcare
  • Luxembourg · Pentoxyvérine Sanofi
  • Norway · Biseltoc
  • Portugal · Bisoltussin
  • Sweden · Biseltoc
  • Slovakia · Stadatussin, Stadatussin Kvapky

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9b2d8157-9543-4a36-8485-0c109d943b59
GET /v1/drugs/9b2d8157-9543-4a36-8485-0c109d943b59?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oral solution",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Balsoclase Antitussivum 2.13 mg/ml",
  "name_fr": "Balsoclase Antitussivum 2.13 mg/ml",
  "name_nl": "Balsoclase Antitussivum 2.13 mg/ml",
  "amp_code": "SAM238393-00",
  "strengths": [
    "2.1300",
    "2.1300",
    "1.3500",
    "1.3500"
  ],
  "pack_count": 1,
  "substances": [
    "Pentoxyverine Citrate",
    "Pentoxyverine"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Pentoxyverine",
  "authorisation_numbers": [
    "BE238393"
  ]
}
API referenceMCP serverPlans

See everything about pentoxyverine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console